Pharmacist-Led Daily Antimicrobial Density Reporting Cuts ICU Consumption
This single-center interrupted time series suggests that a unit-based clinical pharmacist delivering an individualized daily antimicrobial use density report can reduce ICU antimicrobial consumption and cost while shifting prescribing toward narrower agents.
antimicrobial stewardshipclinical pharmacistintensive care unitdefined daily dosescarbapenemstigecyclinefluoroquinolonesWHO AWaReinterrupted time seriesantimicrobial resistanceClinical Pharmacy Practice
Antimicrobial resistance in ICUs poses a serious threat to patient safety, necessitating effective stewardship strategies. The intervention led to a significant reduction in antimicrobial use by 29.0 DDDs/100 patient-days and decreased costs by 8304 CNY per hospitalization. This UBCP-led model shows promise in enhancing antimicrobial stewardship but findings are limited to a single-center ICU. Unit-based clinical pharmacists can significantly improve antimicrobial use and costs in the ICU setting.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Huang T, Zhu D, Luo J, Zhang H, Qiu Y, Wen Y, Liu G, Wen H, Liu T
Citation:Huang T, Zhu D, Luo J, et al. Practice model of unit-based clinical pharmacists' individualized daily antimicrobial use density monitoring report on antimicrobial stewardship in intensive care unit of a tertiary hospital in Guangxi, China: an interrupted time series analysis. Antimicrobial resistance and infection control. 2026;15(1). doi:10.1186/s13756-026-01786-9